MELBOURNE, Australia, Feb. 7, 2025/PRNewswire/ -- Wellumio, a...

MELBOURNE, Australia, Feb. 7, 2025/PRNewswire/ -- Wellumio, a New Zealand-based medical device company pioneering advancements in stroke detection, today announced enrollment of the first patient in the Feasibility, safety, and usability assessment of the Wellumio 'Axana' 0.1T portable magnetic resonance imaging device (Portable MRI study) which will study the ability of the Axana device to detect acute stroke in ED patients.

Hi Vintage, you had me worried there with the word “Pivotal”. Thankfully it looks like it’s the start of thier feasibility study.